Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
360.00
|
|
436.56
|
433.50
|
443.79
|
435.49
|
|
|
9 402 303.39
|
556.00
|
423.27
|
444.04
|
430.51
|
429.43
|
437.03
|
434.375
|
|
|
5 101 939.93
|
441.00
|
422.20
|
439.21
|
432.06
|
430.04
|
438.14
|
430.04
|
|
|
7 252 726.66
|
771.00
|
430.73
|
|
445.87
|
444.69
|
448.93
|
444.69
|
|
|
4 820 399.11
|
416.00
|
|
|
454.11
|
445.77
|
454.11
|
445.92
|
|
|
5 035 416.26
|
574.00
|
330.00
|
|
455.19
|
449.22
|
455.19
|
451.59
|
|
|
10 947 678.90
|
1 121.00
|
434.35
|
444.45
|
440.38
|
430.02
|
444.855
|
440.59
|
|
|
30 932 463.50
|
2 217.00
|
410.00
|
422.70
|
391.33
|
388.09
|
398.13
|
394.84
|
|
|
11 904 823.55
|
1 027.00
|
|
409.00
|
382.59
|
379.76
|
388.12
|
387.15
|
|
|
4 700 448.55
|
446.00
|
370.87
|
385.58
|
378.30
|
377.82
|
382.905
|
378.37
|
|
|
3 176 344.51
|
347.00
|
Argenx S.E., a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer.